Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMoreno-García, E.
dc.contributor.authorPuerta-Alcalde, P.
dc.contributor.authorGariup, G.
dc.contributor.authorFernández-Ruiz, M.
dc.contributor.authorLópez Cortés, Luis
dc.contributor.authorCuervo, G.
dc.contributor.authorAlmirante Gragera, Benito
dc.date.accessioned2022-01-13T13:31:02Z
dc.date.available2022-01-13T13:31:02Z
dc.date.issued2021-06
dc.identifier.citationMoreno-García E, Puerta-Alcalde P, Gariup G, Fernández-Ruiz M, López Cortés LE, Cuervo G, et al. Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies. Open Forum Infect Dis. 2021 Jun;8(6):ofab250.
dc.identifier.issn2328-8957
dc.identifier.urihttp://hdl.handle.net/11351/6784
dc.descriptionAntifúngic; Candidèmia; Desescalada
dc.description.sponsorshipThis research forms part of an activity that has received funding from EIT Health. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union that receives support from the European Union´s Horizon 2020 Research and Innovation Program. This study has been cofunded by the European Regional Development Fund. E. M.-G. (PI18/01061), P. P.-A. (“Rio Hortega” contract CM18/00132), M. F.-R. (“Miguel Servet” contract CP18/00073), and C. G.-V. (FIS PI18/01061) have received research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III.
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofseriesOpen Forum Infectious Diseases;8(6)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectMedicaments antifúngics - Ús terapèutic
dc.subjectMicosi - Tractament
dc.subjectCàndida
dc.subject.meshCandidemia
dc.subject.mesh/drug therapy
dc.subject.meshAntifungal Agents
dc.subject.mesh/therapeutic use
dc.titleEarly Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/ofid/ofab250
dc.subject.decscandidemia
dc.subject.decs/farmacoterapia
dc.subject.decsantifúngicos
dc.subject.decs/uso terapéutico
dc.relation.publishversionhttps://doi.org/10.1093/ofid/ofab250
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Moreno-García E, Puerta-Alcalde P, Gariup G] Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [Fernández-Ruiz M] Hospital Universitario “12 de Octubre”, Instituto de Investigación Hospital “12 de Octubre” (imas+12), Universidad Complutense, Madrid, Spain. [López Cortés LE] Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, CSIC, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Cuervo G] Hospital Universitari de Bellvitge, IDIBELL (Institut d’Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain. [Almirante B] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid34104670
dc.identifier.wos000715364900045
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple